McKesson Co. (NYSE:MCK) Shares Acquired by Czech National Bank

Czech National Bank increased its stake in shares of McKesson Co. (NYSE:MCK - Free Report) by 4.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 28,785 shares of the company's stock after acquiring an additional 1,261 shares during the period. Czech National Bank's holdings in McKesson were worth $19,372,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of MCK. GAMMA Investing LLC increased its holdings in shares of McKesson by 75,632.7% during the 1st quarter. GAMMA Investing LLC now owns 2,393,152 shares of the company's stock valued at $1,610,567,000 after purchasing an additional 2,389,992 shares in the last quarter. Norges Bank acquired a new stake in McKesson during the fourth quarter valued at $1,200,361,000. Farallon Capital Management LLC purchased a new position in McKesson in the fourth quarter valued at $348,044,000. Marshall Wace LLP boosted its position in McKesson by 59,720.3% during the fourth quarter. Marshall Wace LLP now owns 358,922 shares of the company's stock worth $204,553,000 after purchasing an additional 358,322 shares in the last quarter. Finally, Leigh Baldwin & CO. LLC acquired a new stake in McKesson in the fourth quarter valued at approximately $182,861,000. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

McKesson Price Performance

McKesson stock traded up $1.20 during trading on Thursday, reaching $710.66. 614,234 shares of the company were exchanged, compared to its average volume of 916,279. The stock's 50 day simple moving average is $698.91 and its two-hundred day simple moving average is $640.44. The company has a market capitalization of $88.91 billion, a P/E ratio of 32.54, a PEG ratio of 1.29 and a beta of 0.53. McKesson Co. has a 52-week low of $464.42 and a 52-week high of $731.00.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $10.12 earnings per share for the quarter, beating the consensus estimate of $9.83 by $0.29. McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. The firm had revenue of $90.82 billion for the quarter, compared to analysts' expectations of $94 billion. During the same quarter in the previous year, the company posted $6.18 EPS. The company's revenue was up 18.9% compared to the same quarter last year. As a group, equities analysts forecast that McKesson Co. will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 1st. Stockholders of record on Monday, June 2nd will be issued a dividend of $0.71 per share. The ex-dividend date of this dividend is Monday, June 2nd. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.40%. McKesson's dividend payout ratio is currently 10.99%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. UBS Group increased their target price on McKesson from $708.00 to $805.00 and gave the company a "buy" rating in a research report on Tuesday, April 29th. Mizuho increased their price objective on shares of McKesson from $630.00 to $690.00 and gave the company a "neutral" rating in a report on Thursday, April 3rd. Wall Street Zen upgraded shares of McKesson from a "buy" rating to a "strong-buy" rating in a research report on Friday, May 30th. Wells Fargo & Company boosted their target price on shares of McKesson from $691.00 to $766.00 and gave the stock an "equal weight" rating in a research note on Tuesday. Finally, Evercore ISI raised their price target on shares of McKesson from $650.00 to $675.00 and gave the company an "outperform" rating in a research note on Thursday, February 6th. Three investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $692.46.

Insider Activity

In other news, CAO Napoleon B. Rutledge, Jr. sold 543 shares of the company's stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $726.51, for a total value of $394,494.93. Following the transaction, the chief accounting officer now directly owns 1,972 shares in the company, valued at approximately $1,432,677.72. This represents a 21.59% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Thomas L. Rodgers sold 510 shares of McKesson stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $717.91, for a total transaction of $366,134.10. Following the completion of the sale, the executive vice president now owns 5,435 shares of the company's stock, valued at $3,901,840.85. This trade represents a 8.58% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 13,747 shares of company stock valued at $9,852,587. 0.11% of the stock is currently owned by company insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.